BCI Trademark

Trademark Overview

On Tuesday, July 28, 2009, a trademark application was filed for BCI with the United States Patent and Trademark Office. The USPTO has given the BCI trademark a serial number of 77791742. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 22, 2017. This trademark is owned by BrainCells Inc.. The BCI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research and development services, namely, assay development, compound screening, compound and chemical identification, drug target identification and characterization, performance of human clinical trials
bci

General Information

Serial Number77791742
Word MarkBCI
Filing DateTuesday, July 28, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 22, 2017
Registration Number3962475
Registration DateTuesday, May 17, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2009

Trademark Statements

Goods and Servicespharmaceutical research and development services, namely, assay development, compound screening, compound and chemical identification, drug target identification and characterization, performance of human clinical trials
Pseudo MarkBRAIN CELLS INC.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 22, 2017
Primary Code042
First Use Anywhere DateMonday, November 29, 2004
First Use In Commerce DateMonday, November 29, 2004

Trademark Owner History

Party NameBrainCells Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBrainCells Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBrainCells Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, December 22, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, August 23, 2016WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, August 23, 2016TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, May 17, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 17, 2011REGISTERED-PRINCIPAL REGISTER
Friday, April 15, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, April 14, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, April 14, 2011ASSIGNED TO LIE
Thursday, March 31, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 1, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 28, 2011STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 24, 2011USE AMENDMENT FILED
Monday, February 28, 2011EXTENSION 2 GRANTED
Thursday, February 24, 2011EXTENSION 2 FILED
Thursday, February 24, 2011TEAS EXTENSION RECEIVED
Thursday, February 24, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, October 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2010EXTENSION 1 GRANTED
Wednesday, September 15, 2010EXTENSION 1 FILED
Tuesday, October 5, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 15, 2010TEAS EXTENSION RECEIVED
Tuesday, March 23, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 29, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2009PUBLISHED FOR OPPOSITION
Tuesday, November 24, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 24, 2009ASSIGNED TO LIE
Friday, November 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 29, 2009ASSIGNED TO EXAMINER
Saturday, August 1, 2009NOTICE OF PSEUDO MARK MAILED
Friday, July 31, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 31, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

compound development identification characterization target human trials clinical drug performance